ProShare Advisors LLC Raises Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

ProShare Advisors LLC raised its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 20.4% in the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 460,247 shares of the medical equipment provider’s stock after acquiring an additional 77,926 shares during the quarter. ProShare Advisors LLC’s holdings in Intuitive Surgical were worth $240,231,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also modified their holdings of the company. Quantinno Capital Management LP raised its holdings in shares of Intuitive Surgical by 33.5% in the 4th quarter. Quantinno Capital Management LP now owns 30,684 shares of the medical equipment provider’s stock valued at $16,016,000 after purchasing an additional 7,693 shares in the last quarter. Mufg Securities Americas Inc. acquired a new position in Intuitive Surgical in the fourth quarter valued at $2,745,000. Nissay Asset Management Corp Japan ADV increased its stake in Intuitive Surgical by 6.3% in the fourth quarter. Nissay Asset Management Corp Japan ADV now owns 81,790 shares of the medical equipment provider’s stock valued at $43,748,000 after purchasing an additional 4,837 shares during the period. Nomura Holdings Inc. boosted its holdings in shares of Intuitive Surgical by 2.6% in the fourth quarter. Nomura Holdings Inc. now owns 37,541 shares of the medical equipment provider’s stock valued at $19,595,000 after acquiring an additional 936 shares in the last quarter. Finally, Nearwater Capital Markets Ltd purchased a new stake in shares of Intuitive Surgical in the fourth quarter valued at about $54,756,000. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity at Intuitive Surgical

In other Intuitive Surgical news, VP Fredrik Widman sold 810 shares of the stock in a transaction on Monday, March 3rd. The shares were sold at an average price of $573.78, for a total transaction of $464,761.80. Following the transaction, the vice president now directly owns 473 shares in the company, valued at $271,397.94. This represents a 63.13% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, EVP Robert Desantis sold 11,545 shares of the stock in a transaction on Thursday, March 13th. The shares were sold at an average price of $499.22, for a total transaction of $5,763,494.90. Following the transaction, the executive vice president now owns 5,224 shares in the company, valued at $2,607,925.28. This trade represents a 68.85% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders sold 32,680 shares of company stock valued at $16,854,345. Corporate insiders own 0.70% of the company’s stock.

Intuitive Surgical Trading Up 0.4%

ISRG opened at $565.94 on Thursday. The company has a fifty day simple moving average of $502.26 and a 200 day simple moving average of $535.79. The firm has a market cap of $202.84 billion, a price-to-earnings ratio of 88.29, a PEG ratio of 5.85 and a beta of 1.70. Intuitive Surgical, Inc. has a twelve month low of $386.00 and a twelve month high of $616.00.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share for the quarter, beating analysts’ consensus estimates of $1.71 by $0.10. The business had revenue of $2.25 billion during the quarter, compared to analyst estimates of $2.19 billion. Intuitive Surgical had a net margin of 27.81% and a return on equity of 14.55%. During the same period last year, the business earned $1.50 EPS. On average, analysts forecast that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

Several research firms have issued reports on ISRG. Jefferies Financial Group increased their price objective on Intuitive Surgical from $475.00 to $575.00 in a research report on Monday, January 27th. Wells Fargo & Company upped their price target on shares of Intuitive Surgical from $630.00 to $687.00 and gave the company an “overweight” rating in a report on Friday, January 24th. Bernstein Bank boosted their price objective on shares of Intuitive Surgical from $655.00 to $700.00 and gave the company an “overweight” rating in a research report on Monday, January 27th. Royal Bank of Canada cut their price objective on shares of Intuitive Surgical from $630.00 to $605.00 and set an “outperform” rating for the company in a research report on Wednesday, April 23rd. Finally, BTIG Research set a $560.00 price target on shares of Intuitive Surgical and gave the stock a “buy” rating in a research report on Monday, April 14th. Five equities research analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $598.95.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.